Empagliflozin improves glycemic control in HNF1A-MODY
The study evaluated the effects of empagliflozin on glycemic control in adults with HNF1A-MODY, finding significant reductions in glucose levels and improvements in time in range.
Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
The study evaluated the effects of empagliflozin on glycemic control in adults with HNF1A-MODY, finding significant reductions in glucose levels and improvements in time in range.
Switching from premixed insulin to the insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) improved glycemic control in participants with type 2 diabetes.
This study analyzed insulin requirements in children and adolescents with Type 1 Diabetes using a closed-loop insulin delivery system. It found significant increases in total daily insulin doses and the proportion of basal insulin over 48 months.
Magnesium supplementation compared with placebo in adults with type 2 diabetes.
This study evaluated the effects of a multi-disciplinary team nursing model combined with high-fiber dietary intervention on elderly diabetes patients, finding significant improvements in various health outcomes.
Electronic medical record-integrated mobile app for personalized diabetes self-care in adults with type 2 diabetes.
This study evaluated the effectiveness of pharmacotherapy for achieving diabetes remission. It found that both intervention and control groups had patients in remission, with notable weight loss in the intervention group.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.